We would love to hear your thoughts about our site and services, please take our survey here.
I don't believe what Porky says. He got DDDD wrong.
Last year Porky was saying the new lab will cost many millions...
Now we have one, and it cost circa £400k.
Share price will double when we announce our first client (which they've said will be H1).
It's pretty clear ........................ we want Adam on the Board.
Maybe he can continue running his own successful CRO at the same time, or even merge with Valirx.
Share price would double or triple if/when Adam is appointed.
Explain this:
Val: 10m mkt cap
Sareum Holdings Plc (Sar): 90m mkt cap
How ?
We are seriously undervalued. Change BOD (add Adam), end THX exclusivity (the cloud over this company), CLX update, tCRO revenue, etc.
We are making progress... exciting few days/weeks ahead.
Val is undervalued at 10m mkt cap. If Val was listed on Nasdaq we'd be at 500m+ mkt cap. That's how it is.
We should be at least 90-100m mkt cap by now (look at Sareum Holdings Plc they are at 91m mkt cap without the pipeline and soon-to-be income generating CRO lab business). We did make it to 65p in Oct 2021 (where we should be now).
If only Adam was on the board we'd be at 50p overnight................
Well our CRO should be 'revenue generating' in Q2 (at the latest), so that should change things.
Would like to hear more about Kings.
Lots of negativity for BOD - would like to see Adam join board of directors and/or become CEO.
Great to hear, DE.
Agree with everyone here that Adam should be on the BOD / CEO. He is already a large shareholder (owning more than all the Directors put together). He is very busy running a successful CRO. So he has the excellent track record. Would be very positive to the share price.
Hope everyone is having a peaceful Easter.